Vice President, Global Regulatory Affairs
Hiring Company

The hiring company name is
confidential for this listing.
About the Role
Greater Philadelphia, PA Area (On-site)
The Company is seeking a Vice President of Global Regulatory Affairs to provide strategic and operational leadership across a portfolio of therapeutic development programs. The role will shape and execute global regulatory strategies from preclinical development through clinical trials, registration, and lifecycle management. Responsibilities include guiding development plans and regulatory pathways, overseeing submissions, leading health authority interactions, and translating regulatory feedback into actionable plans. The executive will partner across scientific, clinical, operational, quality, and business functions, manage regulatory processes and resources, and represent regulatory perspectives in strategic decisions. They will also build and lead a high-performing regulatory organization and support partnerships, due diligence, and corporate transactions. Candidates must hold an advanced scientific, medical, or healthcare-related degree, such as a PhD, PharmD, or MD, and have significant global regulatory leadership experience in biotechnology or pharmaceuticals. Extensive experience with immune-mediated or autoimmune programs, major submissions, health authority interactions, and development across multiple stages and regions is required. Applicants should bring deep knowledge of global regulatory requirements and drug development, including experience with biologics or other complex therapies and programs advancing through pivotal development, registration, and commercialization. Strong strategic, communication, and cross-functional leadership skills are essential, along with experience building or scaling regulatory teams and exposure to business development, licensing, partnerships, or due diligence.
Functions:
- Legal
Compensation
USD $300,000-$360,000 (salary) per year
About the Company
Clinical-stage biotechnology company developing innovative therapeutic programs
Industry
Biotechnology
Type
Privately Held